Does Operative Management of Epidural Abscesses Increase Healthcare Expenditures up to 1 Year After Treatment?

Abstract

Background The incidence of spinal epidural abscesses is increasing. What is more, they are associated with high rates of morbidity and mortality. Advances in diagnostic imaging and antibiotic therapies have made earlier diagnosis and nonoperative management feasible in appropriately selected patients. Nonoperative treatment also has the advantage of lower immediate healthcare charges; however, it is unknown whether initial nonoperative care leads to higher healthcare charges long term. Questions/purposes (1) Does operative intervention generate higher charges than nonoperative treatment over the course of 1 year after the initial treatment of spinal epidural abscesses? (2) Does the treatment of spinal epidural abscesses in people who actively use intravenous drugs generate higher charges than management in people who do not? Methods This retrospective comparative study at two tertiary academic centers compared adult patients with spinal epidural abscesses treated operatively and nonoperatively from January 2016 through December 2017. Ninety-five patients were identified, with four excluded for lack of billing data and one excluded for concomitant intracranial abscess. Indications for operative management included new or progressive motor deficit, lack of response to nonoperative treatment including persistent or progressive systemic illness, or initial sepsis requiring urgent source control. Of the included patients, 52% (47 of 90) received operative treatment with no differences in age, gender, BMI, and Charlson comorbidity index between groups, nor any difference in 30-day all-cause readmission rate, 1-year reoperation rate, or 2-year mortality. Furthermore, 29% (26 of 90) of patients actively used intravenous drugs and were younger, with a lower BMI and lower Charlson comorbidity index, with no differences in 30-day all-cause readmission rate, 1-year reoperation rate, or 2-year mortality. Cumulative charges at the index hospital discharge and 90 days and 1 year after discharge were compared based on operative or nonoperative management and secondarily by intravenous drug use status. Medical records, laboratory results, and hospital billing data were reviewed for data extraction. Demographic factors including age, gender, region of abscess, intravenous drug use, and comorbidities were extracted, along with clinical factors such as symptoms and ambulatory function at presentation, spinal instability, intensive care unit admission, and complications. The primary outcome was charges associated with care at the index hospital discharge and 90 days and 1 year after discharge. All covariates extracted were included in this analysis using negative binomial regression that accounted for Each author certifies that there are no funding or commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article related to the author or any immediate family members. All ICMJE Conflict of Interest Forms for...

Does Nasal Screening for Methicillin-Resistant Staphylococcus aureus (MRSA) Prevent Deep Surgical Site Infections for Elective Cervical Spinal Fusion?

“…This data repository automatically captures sociodemographic and clinical details for all patients presenting for care within the health care system and has been used in the past to study aspects of orthopedic health care policy. [15][16][17] Operative reports, clinical documentation, medication details, and laboratory results were reviewed for primary data abstraction to obtain surgical indications, procedure details, and clinical factors. Demographic factors were considered as age, sex, race, body mass index (BMI), and smoking status.…”

C-reactive Protein-to-albumin Ratio in Spinal Epidural Abscess: Association with Post-treatment Complications

“…1,2 Regardless, SEA is well known to be associated with high rates of morbidity, mortality, and long-term disability even in the setting of effective treatment. 4,6,7 As a result, there has been broad and long-standing interest to better understand prognostic factors and characteristics capable of informing outcomes and treatment approaches among patients who present with SEA. 5,[7][8][9][10][11][12] Numerous studies have highlighted salient sociodemographic and clinical characteristics, with more recent endeavors focusing on predictive modeling and the role of biomarkers.…”

“…4,5 The treatment of SEA is complicated by the need for a multidisciplinary approach and an associated high morbidity and mortality profile at baseline. [1][2][3][4][5][6] Treating clinicians are challenged to balance the need for invasive surgical procedures against the prospect for neurologic decline and elevated risk of postsurgical complications such as surgical site infection and wound dehiscence. 7,8 The heterogenous nature of SEA means that there is not a uniform risk of adverse events across all patients with the condition.…”

Letter to the Editor: Does Operative Management of Epidural Abscesses Increase Healthcare Expenditures up to 1 Year After Treatment?

“…We read with great interest the paper by Xiong et al [6] published in your highly respected journal. The cost of treating various diseases is important, both to funding institutions and to patients themselves.…”

“…The study by Xiong et al [6] raised some questions that we would like to share. Two major types of spinal epidural abscess are distinguished: spontaneous and iatrogenic (due to surgical and anesthetic interventions).…”